Status:
RECRUITING
Standardized Fecal Microbiota Transplantation for Crohn's Diseases
Lead Sponsor:
The Second Hospital of Nanjing Medical University
Collaborating Sponsors:
The Affiliated Huaian NO.1 People's Hospital of Nanjing Medical University
The First Affiliated Hospital of Air Force Medicial University
Conditions:
Inflammatory Bowel Disease
Crohn's Disease (CD)
Eligibility:
All Genders
Phase:
NA
Brief Summary
The gut microbiota is considered to constitute a "microbial organ" which has pivotal roles in the intestinal diseases and body's metabolism. Evidence from animal and human studies strongly supports th...
Detailed Description
The present clinical trial aims to re-establish a gut functionality state of intestinal flora through FMT as a therapy for CD (all age range,HBI\>4). We established a standard microbiota isolation fro...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Crohn's disease, with the diagnosis remaining unchanged after at least three months of follow-up.
- Willingness to undergo FMT (Fecal Microbiota Transplantation).
Exclusion
- Presence of serious conditions that made them unsuitable for inclusion (e.g., malignant neoplasms, cardiopulmonary failure, serious liver or kidney disease).
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT01793831
Start Date
February 1 2013
End Date
December 1 2025
Last Update
November 29 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University
Huai'an, Jiangsu, China, 223000
2
Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China, 210011